Bioventus Inc. Files 2024 Definitive Proxy Statement
Ticker: BVS · Form: DEF 14A · Filed: Apr 22, 2025 · CIK: 1665988
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
Related Tickers: BVS
TL;DR
Bioventus filed its proxy statement for 2024. Get ready to vote.
AI Summary
Bioventus Inc. filed its definitive proxy statement on April 22, 2025, for the fiscal year ending December 31, 2024. The filing, designated as DEF 14A, outlines information for shareholders regarding the company's annual meeting and related corporate governance matters. The company is headquartered in Durham, NC, and operates in the surgical and medical instruments sector.
Why It Matters
This filing provides shareholders with crucial information for voting on company matters, including director elections and executive compensation, impacting the company's future direction and governance.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) and does not contain new material events or financial disclosures that would inherently increase risk.
Key Players & Entities
- Bioventus Inc. (company) — Registrant
- 0001628280-25-018715 (filing_id) — Accession Number
- 20250422 (date) — Filing Date
- 20241231 (date) — Fiscal Year End
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC 27703 (address) — Business Address
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing is a definitive proxy statement filed with the SEC by a company to provide shareholders with information they need to vote at an upcoming shareholder meeting, such as on director elections and executive compensation.
When was this definitive proxy statement filed by Bioventus Inc.?
Bioventus Inc. filed this definitive proxy statement on April 22, 2025.
What fiscal year does this proxy statement cover?
This proxy statement covers the fiscal year ending December 31, 2024.
Where is Bioventus Inc. headquartered?
Bioventus Inc. is headquartered at 4721 Emperor Boulevard, Suite 100, Durham, NC 27703.
What is Bioventus Inc.'s Standard Industrial Classification (SIC) code?
Bioventus Inc.'s SIC code is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 22, 2025 regarding Bioventus Inc. (BVS).